let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression - Test2 - elhamkhani - TriplyDB

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

http://www.wikidata.org/entity/Q28239424

about

Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma.MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.Therapeutic effects of long-circulating miR-135a-containing cationic immunoliposomes against gallbladder carcinoma.Targeting miRNAs for pancreatic cancer therapy MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG.Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer Towards a clinical use of miRNAs in pancreatic cancer biopsies.MicroRNA regulation of mitogenic signaling networks in the human placenta.Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells.New targeted therapies in pancreatic cancer.Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.microRNA signature for human pancreatic cancer invasion and metastasis.MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk.MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells.Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer

P2860

Q24596298-C35A7B65-08D6-46A1-BDBB-616FC6463105 Q26744298-378B38EB-7D0F-4E24-AC32-B8CB6BBADDDB Q26774628-CEBC664D-9427-4392-977D-056F71120782 Q26799779-97ED1EC8-B90F-4F2C-8079-30ED8148EB47 Q28473944-130792A9-031E-47FB-9387-E27E6D8CFB32 Q28731854-D84F272C-069B-4553-AA7D-C50AE9CAFA84 Q30241331-977C28D5-D51B-4625-AC92-5CF6D6845477 Q33668095-E897F29E-1F84-4D7E-804E-25E75CC4B0C5 Q33801377-F3FB931E-A061-4F8D-90E3-76BB930DC368 Q33823239-A736D691-5CB7-4085-9AB2-EADED00E8806 Q33886348-12B71E4D-3F4A-4683-A456-2879FBF5AB4B Q33921112-C3E9EBA6-D8BE-43BE-BBE5-B91D3B9F8692 Q33962488-865D2412-7B7C-43D2-8E8F-1E0A46DAE45E Q33962495-E7227046-0DC5-44D2-9159-BD1B488B667B Q34003790-CC7E74A7-7D8F-483D-9786-4FB27E548AC7 Q34067856-0E019FCD-B00F-4C87-AC2A-356AA608B130 Q34093798-21D4861F-45B9-4379-89E9-B8CD6C32EF26 Q34318781-C0DD3BBD-408D-46B6-B16F-1342D1B3AF4C Q34430950-8EC26C76-5ED8-4DD3-A816-5D4402B1E7AB Q34555685-08B6B5E3-354A-437F-90D8-68C185B3DC58 Q34576658-956FE2FD-5C0E-4AAF-8CF8-8689EA077EC4 Q34763999-7461A7B0-4EB7-406D-A2C0-C7521150B20E Q34896601-E432610A-B3C8-4A67-B6F4-ACD06BFB2DD1 Q35086717-F37D0181-8B41-48BF-8392-C8529E5B438A Q35196518-52AFB453-0727-4EAA-B5CD-EFB4948D752F Q35588328-0556FBCC-45CB-4F30-9845-D8736336660A Q35604232-74E9CCD4-D1B0-4953-85FA-44886F50F2E7 Q35651453-9C927C0D-93EB-4B40-A347-B20A80835873 Q35735278-27E68994-C834-43E7-AB3B-CA2898713E4B Q35793641-9D21C5A6-7E1B-4C9A-884B-5EA70DFEEE0D Q35881362-ACE3CCF1-A139-4C1C-A143-53A7E11C01B2 Q35888467-AED77367-1562-4AF7-990A-1CC4235EB983 Q35987380-F83C263F-8204-456D-AF2F-C12F4B3E37A3 Q36225874-354EC426-9822-42A5-935C-EB77EFAAE6AE Q36387904-2D243883-DFCC-4481-A231-BBC200CA4FDB Q36492992-86C41828-6DC8-43D3-88D4-BD2135DDE5FC Q36502321-907E21DF-AC58-4F0B-9AAA-85127EF87EED Q36545604-077A7C47-0F7D-47FA-B8CA-B6C51407F4B0 Q36654542-A99E0D5A-10DE-4681-9F3F-21027D9E67AE Q36791689-7D5D8106-BD73-4854-8CBA-6163CAEE34D5

P2860

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

http://www.wikidata.org/entity/Q28239424

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@ast

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@en

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@nl

type

label

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@ast

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@en

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@nl

prefLabel

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@ast

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@en

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@nl

P1433

Q28239424-327FCEC0-7B4E-48AE-8478-40E138E284B8

P1476

Q28239424-267EC6D5-8E47-41A7-817C-529BC80748B2

P2093

Q28239424-076181FA-DCCE-4625-A6A1-2509697BEA7F

Q28239424-1952EEA2-0671-4FB4-BEBB-17DC66D0DC02

Q28239424-1FCA4002-8603-46E5-A2F4-C51BC6411927

Q28239424-299997DF-D436-489C-A664-140B39B65DE8

Q28239424-6DE837D6-3774-4A4F-AE40-E23C5B1DD836

Q28239424-96FA382D-3CDB-4D69-BE3C-D360A29F397A

Q28239424-9E2F9E61-47CE-4BA0-8EC1-2287590D713E

Q28239424-CA59FF5A-2208-41C9-9503-3C7EFB0FEF47

P304

Q28239424-9B974F4D-3563-4B30-97B2-176879F4860A

P31

Q28239424-3A2565C2-D27B-49A4-820F-7CE267DB5041

P3181

Q28239424-CCA2DEF3-9612-43E0-AB31-AE7AEAC7382F

P356

Q28239424-1D196505-9E65-4936-B3FE-63A06FD6D09F

P407

Q28239424-9173FFC1-0C58-4BAC-BB00-FA0FE8F578B6

P433

Q28239424-A759C119-8DE3-4931-B0F1-3FE2B1E46BBE

P478

Q28239424-9D8D53EC-7540-40ED-BABD-C12530D3D2FA

P577

Q28239424-AF5E5AC8-4D69-47C1-885A-834E8AD2E4EF

P698

Q28239424-399F33CC-A602-4D34-8B53-16C92869D710

P921

Q28239424-CED49BC0-F37B-40D5-A7C2-0C65B8A4514F

P3181

P356

P1433

Human Gene Therapy

P1476

let-7 MicroRNA transfer in pan ...... ils to alter tumor progression

@en

P2093

Anny Souque

http://www.w3.org/2001/XMLSchema#string

Barbara Bournet

http://www.w3.org/2001/XMLSchema#string

Jean Escourrou

http://www.w3.org/2001/XMLSchema#string

Jérôme Torrisani

http://www.w3.org/2001/XMLSchema#string

Louis Buscail

http://www.w3.org/2001/XMLSchema#string

Maël Chalret du Rieu

http://www.w3.org/2001/XMLSchema#string

Michèle Bouisson

http://www.w3.org/2001/XMLSchema#string

Pierre Cordelier

http://www.w3.org/2001/XMLSchema#string

P304

831-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

741606

http://www.w3.org/2001/XMLSchema#string

P356

10.1089/HUM.2008.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19323605

http://www.w3.org/2001/XMLSchema#string

P921